Search - tctmd.com

Displaying 1 - 20 of 550

Sort: Relevancy | Date

Q&A Lior Jankelson on AI Tools for Suspected ACS and More

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

February 10, 2026

TCTMD’s Biggest News of 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

FDA Approves Aficamten for Obstructive HCM

News Daily News

FDA Approves Aficamten for Obstructive HCM

December 29, 2025

TCTMD’s Top 10 Most Popular Stories for December 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

Year in Review: Evidence Around AI in Cardiology Grows

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

December 23, 2025

Andexanet Alfa Pulled From US Market

News Daily News

Andexanet Alfa Pulled From US Market

December 22, 2025

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

News Daily News

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

December 16, 2025

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

Front-of-Package Nutrition Info Backed by ACC to Improve CV Health

News Daily News

Front-of-Package Nutrition Info Backed by ACC to Improve CV Health

December 10, 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

October 27, 2025

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

October 22, 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

TCTMD's Top 10 Most Popular Stories for August 2025

News Opinion Editor's Corner

TCTMD's Top 10 Most Popular Stories for August 2025

August 28, 2025

Evolocumab Gains Expanded Indication for Primary Prevention

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

TCTMD’s Top 10 Most Popular Stories for July 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

July 31, 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

July 24, 2025

TCTMD’s Top 10 Most Popular Stories for June 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines

News Daily News

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines

Michael O'Riordan

June 26, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.